See also this year's filing and all EDGAR filings for this company.
PDF Report 0001505512_2023_Regulus_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001505512, Regulus Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 44,079,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 62,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 2,575,000 |
| 4 | LiabilitiesCurrent | 11,657,000 |
| 5 | LiabilitiesNoncurrent | 1,768,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,829,000 |
| 9 | ResearchAndDevelopmentExpense | 18,410,000 |
| 10 | remainder_Expenses | 689,000 |
| 11 | remainder_Revenues | 605,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -12,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 46,716,000 |
| 1 | Liabilities | 13,425,000 |
| 2 | Expenses | 28,928,000 |
| 3 | Revenues | 605,000 |
| 4 | StockholdersEquity | 33,291,000 |
| 5 | NetIncome | -28,323,000 |
| 6 | ComprehensiveNetIncome | -28,329,000 |
| 7 | BaseVar | 44,843,000 |
| 8 | EconomicCapitalRatio | 0.962 |
Edgar->Model Mapping
Feature Distribution
Change over Time
